108 related articles for article (PubMed ID: 26720024)
1. Prevention of Premature Menopause and Preservation of Fertility in Young Cancer Survivors: Hopeful Though Modest Long-term Results.
Partridge AH
JAMA; 2015 Dec 22-29; 314(24):2625-7. PubMed ID: 26720024
[No Abstract] [Full Text] [Related]
2. Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy?
Partridge AH
J Clin Oncol; 2012 Feb; 30(5):479-81. PubMed ID: 22231046
[No Abstract] [Full Text] [Related]
3. Gonadotropin-releasing hormone agonist for preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Blumenfeld Z
J Clin Oncol; 2012 Sep; 30(26):3310; author reply 3312-3. PubMed ID: 22649145
[No Abstract] [Full Text] [Related]
4. Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy.
Tomao F; Benedetti Panici P; Tomao S
J Clin Oncol; 2012 Sep; 30(26):3310-1; author reply 3312-3. PubMed ID: 22649128
[No Abstract] [Full Text] [Related]
5. Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
Lambertini M; Boni L; Michelotti A; Gamucci T; Scotto T; Gori S; Giordano M; Garrone O; Levaggi A; Poggio F; Giraudi S; Bighin C; Vecchio C; Sertoli MR; Pronzato P; Del Mastro L;
JAMA; 2015 Dec 22-29; 314(24):2632-40. PubMed ID: 26720025
[TBL] [Abstract][Full Text] [Related]
6. Potential late effect of gonadotropin-releasing hormone agonists in combination with chemotherapy for early breast cancer.
Saloustros E; Stratakis CA
J Clin Oncol; 2012 Sep; 30(26):3311-2. PubMed ID: 22649148
[No Abstract] [Full Text] [Related]
7. Reproductive endocrinology: triptorelin ovarian suppression during breast cancer chemotherapy.
Ginsburg ES; Partridge AH
Nat Rev Endocrinol; 2011 Sep; 7(11):637-8. PubMed ID: 21931373
[No Abstract] [Full Text] [Related]
8. [Role of ovarian suppression in the combined treatment of breast cancer patients in premenopause].
Shchepotin IB; Zotov AS; Liubota RV; Anikus'ko NF; Liubota II
Vopr Onkol; 2013; 59(3):397-404. PubMed ID: 23909046
[No Abstract] [Full Text] [Related]
9. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
[TBL] [Abstract][Full Text] [Related]
10. Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.
Meattini I; Saieva C; Meacci F; Scotti V; De Luca Cardillo C; Desideri I; Baldazzi V; Mangoni M; Scoccianti S; Detti B; Simontacchi G; Nori J; Orzalesi L; Sanchez L; Casella D; Bernini M; Fambrini M; Bianchi S; Livi L
Future Oncol; 2016 Mar; 12(5):625-35. PubMed ID: 26837239
[TBL] [Abstract][Full Text] [Related]
11. 3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience.
Caruso M; Castiglione G; Aiello R; Alí M; Chiarenza M; Dimarco R; Fallica G; Di Leo MG; Sanó MV; Taibi E; Zacchia A; Miano E; Caruso F
Future Oncol; 2015; 11(23):3109-12. PubMed ID: 26544787
[No Abstract] [Full Text] [Related]
12. Trying to reduce ovarian damage in patients with Hodgkin lymphoma using GnRH agonists?
Oktay K; Sonmezer M; Barad D; Gleicher N
Fertil Steril; 2009 Jan; 91(1):298-9; author reply 299. PubMed ID: 19046580
[No Abstract] [Full Text] [Related]
13. Triptorelin approved for prostate cancer treatment.
Millar JL
Am J Health Syst Pharm; 2000 Aug; 57(15):1386. PubMed ID: 10938976
[No Abstract] [Full Text] [Related]
14. Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer.
Loibl S; Gerber B
JAMA; 2011 Oct; 306(16):1760; author reply 1760-1. PubMed ID: 22028347
[No Abstract] [Full Text] [Related]
15. Triptorelin improves intestinal symptoms among patients with colorectal endometriosis.
Ferrero S; Camerini G; Ragni N; Menada MV; Venturini PL; Remorgida V
Int J Gynaecol Obstet; 2010 Mar; 108(3):250-1. PubMed ID: 19944420
[No Abstract] [Full Text] [Related]
16. [Role of GnRH agonists in preserving female fertility].
Thomin A; Torre A; Daraï É; Chabbert-Buffet N
J Gynecol Obstet Biol Reprod (Paris); 2014 Apr; 43(4):267-74. PubMed ID: 24321862
[TBL] [Abstract][Full Text] [Related]
17. [Decapeptyl (triptorelin) in the treatment of endometriosis genitalis externa].
Palatyński A; Gruszczyńska J
Ginekol Pol; 2001 May; 72(5):290-5. PubMed ID: 11526759
[TBL] [Abstract][Full Text] [Related]
18. Reducing the long-term effects of chemotherapy in young women with early-stage breast cancer.
Rugo HS; Rosen MP
JAMA; 2011 Jul; 306(3):312-4. PubMed ID: 21771995
[No Abstract] [Full Text] [Related]
19. What is new in reproductive endocrinology?: best articles from the past year.
Liu JH
Obstet Gynecol; 2012 May; 119(5):1052-4. PubMed ID: 22525920
[No Abstract] [Full Text] [Related]
20. [APPLICATION OF DIFERELIN AND ITS PERSPECTIVES].
Rapoport LM; Bezrukov EA; Demidko JL; Kondrashina AV
Urologiia; 2015; (2):43-4, 46. PubMed ID: 26237805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
